Clinical
RSSArticles
-
Vaginally Inserted Contraceptives Can Fill Care Gap for Some
Women around the world lack awareness about most of the vaginally inserted contraceptive methods. This poses the biggest barrier to their use, researchers found. Product cost is another major barrier to adoption, as are unsupportive partner attitudes and women’s concerns about insertion. The most important enabling factor to a person’s use of vaginally inserted contraceptives is counseling from a trained provider or community health worker.
-
Patients with Bleeding Disorders Report IUD Expulsion Rates Similar to Others
The results of recent research suggest clinicians should not hesitate to insert a hormonal IUD in patients with a bleeding disorder because their IUD expulsion rate is similar to that of other women with heavy bleeding but without a bleeding disorder diagnosis.
-
More Support Needed for Contraceptive Healthcare at Student Health Centers
States, universities, and the sexual and reproductive health community need to help students obtain optimal contraceptive and reproductive healthcare through the most convenient place for students — the college health center, according to recent research.
-
Ways to Help Patients with Bleeding from Contraceptive Implant
Some patients experience bothersome uterine bleeding after receiving a contraceptive implant, according to a new study of implants and adolescent/young adult patients. Investigators found that 27% of people with an average age of about 19 years reported subsequent bleeding. Those who reported irregular menses before the implant were more likely to report bleeding after receiving the implant.
-
Patients Who Experience Homelessness Face Multiple Barriers to Contraceptive Care
Homelessness adds multiple barriers to contraception counseling and care. These patients often cannot access OB/GYNs or family planning clinics because of transportation and insurance obstacles. It is important for all clinicians to ask patients experiencing homelessness about their contraceptive needs and to counsel them on all methods.
-
RSV Vaccine for Older Patients Receives Support
FDA approved Arexvy to protect people age 60 years and older against the respiratory syncytial virus.
-
First Oral Fecal Microbiota Product Wins FDA Approval
There is a new tool available in the battle against one of the most common healthcare-associated infections in the United States.
-
Researchers Use Advanced Technology to Detect MIS-C
Scientists want to improve diagnostic techniques for multisystem inflammatory syndrome in children, which became a confounding problem during the COVID-19 pandemic.
-
Viral Exposure and the Risk of Developing Neurodegenerative Disease
In two national European biobanks, researchers identified and replicated 22 pairs of viral exposures associated with a higher risk of neurodegenerative diseases.
-
Is It Safe and Effective to Use Low-Dose Opioids Long Term to Treat Refractory RLS?
A review of two-year longitudinal data regarding efficacy and dose stability in refractory restless legs syndrome (RLS) patients treated with low-dose opioids shows that patients do not escalate their opiate dosage and that there is clinical and therapeutic stability in treating RLS with this therapeutic regimen.